Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.
about
Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies.Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.Prenatal pharmacogenomics: a promising area for research.The role of formulation on the pharmacokinetics of antiretroviral drugs.Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.Pharmacogenetic Analysis of the Model-Based Pharmacokinetics of Five Anti-HIV Drugs: How Does This Influence the Effect of Aging?Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics.Pharmacogenetics of nevirapine excretion into breast milk and infants' exposure through breast milk versus postexposure prophylaxis.Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
P2860
Q28821119-B6726AC0-193A-4177-846F-9B65D51CE40AQ33946645-4E5AB1A3-D8BD-409A-8925-BD7C7D34B180Q35908584-1D47FF39-FA3E-49AB-9C1A-83B3958B544DQ37013956-83559F73-5E7D-4478-8290-4AB37945CCD4Q37116083-F448D421-F9F4-413B-BE75-07184E00AD9CQ38216047-CA25F8C0-B485-4203-B5D5-09DD039D4144Q42713259-D0E81D64-A612-497D-896E-CA96F9D74F23Q44877659-E5670151-58E2-41CB-989D-FB3F34929BC9Q46158508-61FD8E1B-8B9C-4E07-ADB4-9DBE9F58E3E4Q46828123-3155C1D3-A3B9-4269-BE09-253F713AAA78Q50568163-C7EC87B9-DBB6-4121-B4EE-99370647998DQ58073610-DB208AAD-A19B-4CB0-8E35-3B1057C304F6
P2860
Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Potential effect of pharmacoge ...... g pregnancy and breastfeeding.
@en
type
label
Potential effect of pharmacoge ...... g pregnancy and breastfeeding.
@en
prefLabel
Potential effect of pharmacoge ...... g pregnancy and breastfeeding.
@en
P2860
P50
P356
P1433
P1476
Potential effect of pharmacoge ...... ng pregnancy and breastfeeding
@en
P2093
Tim R Cressey
P2860
P304
P356
10.2217/PGS.12.138
P577
2012-10-01T00:00:00Z